Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Metabolic abnormalities in pain-processing regions of patients with fibromyalgia: a 3T MR spectroscopy study.

Feraco P, Bacci A, Pedrabissi F, Passamonti L, Zampogna G, Pedrabissi F, Malavolta N, Leonardi M.

AJNR Am J Neuroradiol. 2011 Oct;32(9):1585-90. doi: 10.3174/ajnr.A2550. Epub 2011 Jul 28.

2.

Proton MR spectroscopy in the evaluation of cerebral metabolism in patients with fibromyalgia: comparison with healthy controls and correlation with symptom severity.

Petrou M, Harris RE, Foerster BR, McLean SA, Sen A, Clauw DJ, Sundgren PC.

AJNR Am J Neuroradiol. 2008 May;29(5):913-8. doi: 10.3174/ajnr.A0959. Epub 2008 Mar 13.

3.

Localized 1H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and N-acetylaspartate.

Fayed N, Garcia-Campayo J, Magallón R, Andrés-Bergareche H, Luciano JV, Andres E, Beltrán J.

Arthritis Res Ther. 2010;12(4):R134. doi: 10.1186/ar3072. Epub 2010 Jul 7.

4.

Metabolite differences in the lenticular nucleus in type 2 diabetes mellitus shown by proton MR spectroscopy.

Lin Y, Zhou J, Sha L, Li Y, Qu X, Liu L, Chen H, An Z, Wang Y, Sun C.

AJNR Am J Neuroradiol. 2013 Sep;34(9):1692-6. doi: 10.3174/ajnr.A3492. Epub 2013 Apr 18.

5.

Hippocampus dysfunction may explain symptoms of fibromyalgia syndrome. A study with single-voxel magnetic resonance spectroscopy.

Emad Y, Ragab Y, Zeinhom F, El-Khouly G, Abou-Zeid A, Rasker JJ.

J Rheumatol. 2008 Jul;35(7):1371-7. Epub 2008 May 15.

PMID:
18484688
6.

Increased glutamate/glutamine compounds in the brains of patients with fibromyalgia: a magnetic resonance spectroscopy study.

Valdés M, Collado A, Bargalló N, Vázquez M, Rami L, Gómez E, Salamero M.

Arthritis Rheum. 2010 Jun;62(6):1829-36. doi: 10.1002/art.27430.

7.

Elevated insular glutamate in fibromyalgia is associated with experimental pain.

Harris RE, Sundgren PC, Craig AD, Kirshenbaum E, Sen A, Napadow V, Clauw DJ.

Arthritis Rheum. 2009 Oct;60(10):3146-52. doi: 10.1002/art.24849.

8.

Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fibromyalgia.

Harris RE, Sundgren PC, Pang Y, Hsu M, Petrou M, Kim SH, McLean SA, Gracely RH, Clauw DJ.

Arthritis Rheum. 2008 Mar;58(3):903-7. doi: 10.1002/art.23223.

9.

Myoinositol and glutamate complex neurometabolite abnormality after mild traumatic brain injury.

Kierans AS, Kirov II, Gonen O, Haemer G, Nisenbaum E, Babb JS, Grossman RI, Lui YW.

Neurology. 2014 Feb 11;82(6):521-8. doi: 10.1212/WNL.0000000000000105. Epub 2014 Jan 8.

10.

Atypical antipsychotic drug treatment for 6 months restores N-acetylaspartate in left prefrontal cortex and left thalamus of first-episode patients with early onset schizophrenia: A magnetic resonance spectroscopy study.

Gan JL, Cheng ZX, Duan HF, Yang JM, Zhu XQ, Gao CY.

Psychiatry Res. 2014 Jul 30;223(1):23-7. doi: 10.1016/j.pscychresns.2014.04.010. Epub 2014 Apr 28.

PMID:
24831926
11.

Effects of antidepressant treatment on N-acetyl aspartate and choline levels in the hippocampus and thalami of post-stroke depression patients: a study using (1)H magnetic resonance spectroscopy.

Huang Y, Chen W, Li Y, Wu X, Shi X, Geng D.

Psychiatry Res. 2010 Apr 30;182(1):48-52. doi: 10.1016/j.pscychresns.2009.11.009. Epub 2010 Mar 15.

PMID:
20227856
12.

Excitatory and inhibitory brain metabolites as targets of motor cortex transcranial direct current stimulation therapy and predictors of its efficacy in fibromyalgia.

Foerster BR, Nascimento TD, DeBoer M, Bender MA, Rice IC, Truong DQ, Bikson M, Clauw DJ, Zubieta JK, Harris RE, DaSilva AF.

Arthritis Rheumatol. 2015 Feb;67(2):576-81.

13.

Changes in metabolites after treatment with memantine in fibromyalgia. A double-blind randomized controlled trial with magnetic resonance spectroscopy with a 6-month follow-up.

Fayed N, Olivan-Blázquez B, Herrera-Mercadal P, Puebla-Guedea M, Pérez-Yus MC, Andrés E, López del Hoyo Y, Magallon R, Viguera L, Garcia-Campayo J.

CNS Neurosci Ther. 2014 Nov;20(11):999-1007. doi: 10.1111/cns.12314. Epub 2014 Sep 17.

PMID:
25230216
14.

Higher glutamate+glutamine and reduction of N-acetylaspartate in posterior cingulate according to age range in patients with cognitive impairment and/or pain.

Fayed N, Andrés E, Viguera L, Modrego PJ, Garcia-Campayo J.

Acad Radiol. 2014 Sep;21(9):1211-7. doi: 10.1016/j.acra.2014.04.009. Epub 2014 Jun 26.

PMID:
24981958
15.

Multi-voxel magnetic resonance spectroscopy at 3 T in patients with idiopathic generalised epilepsy.

Doelken MT, Mennecke A, Stadlbauer A, Kecskeméti L, Kasper BS, Struffert T, Doerfler A, Stefan H, Hammen T.

Seizure. 2010 Oct;19(8):485-92. doi: 10.1016/j.seizure.2010.07.005. Epub 2010 Aug 4.

16.

Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.

Tandon N, Bolo NR, Sanghavi K, Mathew IT, Francis AN, Stanley JA, Keshavan MS.

Schizophr Res. 2013 Aug;148(1-3):59-66. doi: 10.1016/j.schres.2013.05.024. Epub 2013 Jun 20.

PMID:
23791389
17.

Elevated metabolites within dorsolateral prefrontal cortex in rapid cycling bipolar disorder.

Michael N, Erfurth A, Pfleiderer B.

Psychiatry Res. 2009 Apr 30;172(1):78-81. doi: 10.1016/j.pscychresns.2009.01.002. Epub 2009 Feb 23.

PMID:
19239983
18.

Brain dysfunction in fibromyalgia and somatization disorder using proton magnetic resonance spectroscopy: a controlled study.

Fayed N, Andres E, Rojas G, Moreno S, Serrano-Blanco A, Roca M, Garcia-Campayo J.

Acta Psychiatr Scand. 2012 Aug;126(2):115-25. doi: 10.1111/j.1600-0447.2011.01820.x. Epub 2011 Dec 30.

PMID:
22211322
19.

Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus.

Yoo SY, Yeon S, Choi CH, Kang DH, Lee JM, Shin NY, Jung WH, Choi JS, Jang DP, Kwon JS.

Schizophr Res. 2009 Jun;111(1-3):86-93. doi: 10.1016/j.schres.2009.03.036. Epub 2009 Apr 29.

PMID:
19406622
20.

Valproate-induced metabolic changes in patients with epilepsy: assessment with H-MRS.

Garcia M, Huppertz HJ, Ziyeh S, Buechert M, Schumacher M, Mader I.

Epilepsia. 2009 Mar;50(3):486-92. doi: 10.1111/j.1528-1167.2008.01801.x. Epub 2008 Oct 3.

Supplemental Content

Support Center